Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: a multi-center retrospective study

被引：0

作者：

Shragai, Tamir ^{[1
]}

Magen, Hila ^{[2
]}

Lavi, Noa ^{[3
]}

Gatt, Moshe ^{[4
]}

Trestman, Svetlana ^{[1
]}

Zektser, Miri ^{[5
]}

Ganzel, Chezi ^{[6
]}

Jarchowsky, Osant ^{[7
]}

Berger, Tamar ^{[8
]}

Tadmor, Tamar ^{[9
]}

Leiba, Merav ^{[10
]}

Hertzog-Zarfaty, Katrin ^{[11
]}

Horowitz, Netanel ^{[3
]}

Shapira, Michael ^{[12
]}

Varssano, David ^{[1
]}

Berger, Yoav ^{[2
]}

Frenkel, Shahar ^{[4
]}

Krauthammer, Mark ^{[1
]}

Avivi, Irit ^{[13
,14
]}

Luttwak, Efrat ^{[1
]}

Cohen, Yael ^{[13
,14
]}

机构：

[1] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel

[2] Sheba Med Ctr, Ramat Gan, Israel

[3] Rambam Hlth Care Campus, Haifa, Israel

[4] Hadassah Med Ctr, Jerusalem, Israel

[5] Soroka Univ Hosp, Beer Sheva, Israel

[6] Shaare Zedek Med Ctr, Jerusalem, Israel

[7] Meir Med Ctr, Kefar Sava, Israel

[8] Rabin Med Ctr, Petah Tiqwa, Israel

[9] Bnei Zion Med Ctr, Haifa, Israel

[10] Assuta Ashdod Med Ctr, Ashdod, Israel

[11] Shamir Med Ctr, Beer Yaagov, Israel

[12] Assuta Ramat HaChayal Hosp, Tel Aviv, Israel

[13] Tel Aviv Sourasky Ichilov Med Ctr, Tel Aviv, Israel

[14] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-114

引用

页码：S98 / S98

页数：1

共 50 条

[1] Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study
Shragai, Tamir
Magen, Hila
Lavi, Noa
Gatt, Moshe
Trestman, Svetlana
Zektser, Miri
Ganzel, Chezi
Jarchowsky, Osnat
Berger, Tamar
Tadmor, Tamar
Leiba, Merav
Hertzog-Tzarfaty, Katrin
Horowitz, Netanel
Shapira, Michael
Varssano, David
Berger, Yoav
Frenkel, Shahar
Krauthammer, Mark
Avivi, Irit
Luttwak, Efrat
Cohen, Yael C.
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (01) : 45 - 53
[2] Retrospective, single-center, real-world experience of belantamab mafodotin in relapsed/refractory multiple myeloma
Becnel, Melody
Ferreri, Christopher
Feng, Lei
Richards, Tiffany
Horowitz, Sandra
Patel, Nimisha
Gombos, Dan
Razmandi, Azadeh
Murga, Astrid
Seif, Sherif
Youssef, George
Murphy, Kevin
Kaufman, Gregory
Weber, Donna
Patel, Krina
Thomas, Sheeba
Manasanch, Elisabet
Orlowski, Robert
Lee, Hans
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S163 - S164
[3] Retrospective, single-center, real-world experience of belantamab mafodotin in relapsed/refractory multiple myeloma.
Becnel, Melody
Ferreri, Christopher J.
Feng, Lei
Richards, Tiffany Ann
Horowitz, Sandra B.
Patel, Nimisha
Gombos, Dan S.
Razmandi, Azadeh
Murga, Astrid
Seif, Sherif
Youssef, George
Murphy, Kevin
Kaufman, Gregory Peter
Weber, Donna M.
Patel, Krina K.
Thomas, Sheeba K.
Manasanch, Elisabet Esteve
Orlowski, Robert Z.
Lee, Hans C.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[4] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Single Center Experience
Hultcrantz, Malin
Derkach, Andriy
Hassoun, Hani
Korde, Neha
Maclachlan, Kylee H.
Mailankody, Sham
Patel, Dhwani
Shah, Urvi A.
Tan, Carlyn
Akhlaghi, Theresia
Hamadeh, Issam S.
Chung, David J.
Lahoud, Oscar B.
Landau, Heather
Scordo, Michael
Shah, Gunjan L.
Giralt, Sergio A.
Lesokhin, Alexander M.
Usmani, Saad
BLOOD, 2022, 140 : 7246 - 7248
[5] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Experience
Hultcrantz, Malin
Orozco, Jennifer
Peterson, Tim J.
Derkach, Andriy
Hassoun, Hani
Korde, Neha
Lu, Sydney X.
Mailankody, Sham
Patel, Dhwani
Shah, Urvi A.
Tan, Carlyn
Maclachlan, Kylee H.
Chung, David J.
Landau, Heather J.
Shah, Gunjan L.
Lahoud, Oscar B.
Scordo, Michael
Landgren, Ola
Giralt, Sergio
Lesokhin, Alexander
BLOOD, 2021, 138
[6] A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
Dileo, Rachel
Mewawalla, Prerna
Babu, Kalaivani
Yin, Yue
Strouse, Christopher
Chen, Ethan
Shaikh, Hira
Davis, James A.
Green, Kimberly M.
Alkharabsheh, Omar
Rashid, Aliya
Pokhrel, Bidushi
Ahmed, Nausheen
Abdallah, Al-Ola
Hashmi, Hamza
BLOOD CANCER JOURNAL, 2025, 15 (01):
[7] Belantamab Mafodotin in Relapsed/Refractory AL Amyloidosis: Real-World Multi-Center Experience and Review of the Literature
Lebel, Eyal
Vainstein, Vladimir
Milani, Paolo
Palladini, Giovanni
Shragai, Tamir
Lavi, Noa
Magen, Hila
Assayag, Miri
Avivi, Irit
Gatt, Moshe E.
ACTA HAEMATOLOGICA, 2024,
[8] Belantamab mafodotin for relapsed/refractory multiple myeloma: a real-world observational study update
Hultcrantz, Malin
Kleinman, David
Vij, Ravi
Escalante, Fernando
Delforge, Michel
Kotowsky, Nirali
Bitetti, Jacopo
Boytsov, Natalie
Camadoo-O'Byrne, Leena
Happ, Lindsey Powers
Rohman, Mujib
Germain, Guillaume
Duh, Mei Sheng
Laliberte, Francois
Mahendran, Malena
Urosevic, Ana
Lee, Hans
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S185 - S186
[9] Belantamab Mafodotin for Relapsed or Refractory Multiple Myeloma: A Real-World Observational Study Update
Hultcrantz, Malin
Kleinman, David
Vij, Ravi
Escalante, Fernando
Delforge, Michel
Kotowsky, Nirali
Bitetti, Jacopo
Boytsov, Natalie
Camadoo-O'Byrne, Leena
Happ, Lindsey Powers
Rohman, Mujib
Germain, Guillaume
Duh, Mei Sheng
Laliberte, Francois
Mahendran, Malena
Urosevic, Ana
Lee, Hans
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S504 - S504
[10] Belantamab Mafodotin (Belamaf) for Relapsed/Refractory Multiple Myeloma (RRMM): A Real-World Observational Study
Hultcrantz, Malin
Kleinman, David
Vij, Ravi
Escalante, Fernando
Kotowsky, Nirali
Bitetti, Jacopo
Mackay, Christine
Boytsov, Natalie
Camadoo-O'Byrne, Leena
Germain, Guillaume
Duh, Mei Sheng
Laliberte, Francois
Mahendran, Malena
Urosevic, Ana
Lee, Hans C.
BLOOD, 2022, 140 : 10124 - 10126

← 1 2 3 4 5 →